Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(21/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(21/week)
News
United States
(618/week)
Manufacturing
(440/week)
Energy
(341/week)
Technology
(486/week)
Other Manufacturing
(364/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Beta thalassemia
Feb 26, 2020
Thalassemia Treatment Market Outlook to 2025 by Treatment Type, Disease Type, End-user and Geography
Dec 03, 2019
Protagonist Therapeutics Announces Preliminary Phase 2 Results with Hepcidin Mimetic PTG-300 in the Treatment of Transfusion Dependent Beta-Thalassemia
Nov 08, 2019
FDA approves first therapy to treat patients with rare blood disorder
May 29, 2019
Cooley's Anemia Foundation Celebrates a New Era of Hope for Thalassemia Patients Annual Gala Honors Global Foundation Leadership & Patient Activist
Jan 09, 2019
Protagonist Therapeutics Initiates Phase 2 Trial of Novel Hepcidin Mimetic PTG-300 for the Treatment of Patients with Beta Thalassemia
Nov 06, 2018
Protagonist Therapeutics Reports Third Quarter 2018 Financial Results and Provides Corporate Update
Sep 12, 2018
Global Thalassemia Drugs Market 2018-2022
Sep 11, 2018
Global Thalassemia Drugs Market 2018-2022 with ApoPharma, Fresenius Kabi, Novartis, Pfizer & Teva Pharmaceutical Industries Dominating
Jun 18, 2018
Protagonist Announces Phase 1 and Pre-clinical Data on Hepcidin Mimetic PTG-300 Presented at European Hematology Association Annual Meeting
May 31, 2018
Thalassemia Treatment Market to Collect US$ 1,639.6 Mn by 2026, Says TMR
May 17, 2018
Protagonist Therapeutics Announces Two Oral Presentations Accepted for 23rd Congress of the European Hematology Association
Apr 12, 2018
Thalassemia Market Size Worth $3.53 Billion by 2022 | CAGR: 10.8%: Grand View Research, Inc.
Mar 06, 2018
FDA Grants Orphan Drug Designation for Protagonist Therapeutics' PTG-300 for the Treatment of Beta-Thalassemia
Oct 02, 2017
Sangamo And Bioverativ Announce FDA Acceptance Of IND Application For ST-400 -- A Gene-Edited Cell Therapy Candidate -- To Treat Beta-Thalassemia
Jun 23, 2017
European Hematology Association: Treating Sickle Cell Disease and Beta-Thalassemia with CRISPR/Cas9 Gene Editing
Jun 08, 2017
Canadian Scientists Honored for Role in Breakthrough Drug
Latest News
May 4, 2024
Anaergia Announces Additional Delay in the Filing of Its Audited Financial Statements and Related Disclosures
May 4, 2024
Electriq Power Holdings, Inc. Announces Chapter 7 Bankruptcy Filing
May 4, 2024
OSI Systems President and CEO Deepak Chopra to Retire by Calendar Year-End, Will Remain as Executive Chairman
May 4, 2024
Chesapeake Granite Wash Trust Announces Distribution of $0.0098 Per Common Unit
May 4, 2024
High School Women Launch First of its Kind Energy Literacy Podcast
May 4, 2024
Quantum Provides Updated Plan to Nasdaq
May 4, 2024
Tennant Company Announces Senior Leadership Updates to Direct ERP Transformation and Drive Product Innovation
May 4, 2024
OSI Systems to Present at Oppenheimer 19th Annual Industrial Growth Conference
View all News
Agenda
29
October
United Kingdom
Copthorne Tara Hotel, London, UK
International Dismounted Soldier, 29-30 October 2024, Copthorne Tara Hotel, London, UK
Navigating the Evolving Battlespace: Enhancing the Capabilities of the Dismounted Soldier The modern battlefield...
24
September
United Kingdom
Hilton London Syon Park, London, UK
Defence Transformation Conference, 24-26 September 2024, Hilton London Syon Park, London, UK
Returning for its 8th year, Defence Transformation 2024 will feature an updated format that will address all aspects of...
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
View All Events